Invanz and Scab - a phase IV clinical study of FDA data

Summary:

Scab is reported as a side effect among people who take Invanz (ertapenem sodium), especially for people who are female, 50-59 old, also take Lasix, and have Osteoporosis.

The phase IV clinical study analyzes which people have Scab when taking Invanz. It is created by eHealthMe based on reports of 3,924 people who have side effects when taking Invanz from the FDA, and is updated regularly.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

What is Scab?

Scab (a hard coating on the skin formed during the wound healing) is found to be associated with 854 drugs and 1,081 conditions by eHealthMe. Check the latest studies of Scab.

On Jul, 18, 2026

3,924 people reported to have side effects when taking Invanz.
Among them, 27 people (0.69%) have Scab.

Among these 27 people:

What is the gender of people who have Scab when taking Invanz? *

female: 92.59 %
male: 7.41 %

What is the age of people who have Scab when taking Invanz? *

What are other drugs people take besides Invanz? *

What are other side effects people have besides Scab? *

Oedema Peripheral (superficial swelling): 27 people, 100.00%
Bone Pain: 26 people, 96.30%
Pain: 26 people, 96.30%
Swelling: 24 people, 88.89%
Swallowing Difficulty: 24 people, 88.89%
Gingival Infection (gum infection): 24 people, 88.89%
Diarrhea: 24 people, 88.89%
Pneumonia: 24 people, 88.89%
Pleural Effusion (water on the lungs): 24 people, 88.89%
Metastatic Neoplasm (spreadable cancer tumour): 24 people, 88.89%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 23 people, 85.19%
Osteoporosis (bones weak and more likely to break): 23 people, 85.19%
Thrombocytopenia (decrease of platelets in blood): 5 people, 18.52%
Cardiac Failure Chronic: 3 people, 11.11%
Blood Pressure Abnormal: 3 people, 11.11%
Anaemia (lack of blood): 3 people, 11.11%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 7.41%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 3.70%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Invanz and have Scab?

- Check whether Scab is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invanz:

Invanz (3,961 reports)

Scab treatments and more:

Scab (12,679 reports)

Browse all side effects of Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scab:

Scab (854 drugs)

Browse all the conditions that are associated with Scab:

Scab (1,081 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ertapenem sodium (the active ingredients of Invanz) and Invanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.